How do I hire an outsourced CRO for a medtech company in 2027?
Direct Answer
For a medtech company, a fractional CRO can be a smart alternative to a full-time hire when you need senior revenue leadership but can’t justify a $250,000–$400,000 base salary plus benefits and equity. The key is honesty about what you actually need: a CRO who will build a sales process, manage a small team, and navigate medtech’s long buying cycles and compliance requirements. You are not hiring a generalist — you need someone who understands FDA regulatory timelines, hospital procurement, and the difference between selling to a surgeon versus a hospital administrator. The cost range reflects the CRO’s seniority, the number of days per month they commit, and whether you offer equity. Most fractional CROs in medtech will not relocate; they work remotely or travel to your site monthly.
Direct Answer
For a medtech company, a fractional CRO can be a smart alternative to a full-time hire when you need senior revenue leadership but can’t justify a $250,000–$400,000 base salary plus benefits and equity. The key is honesty about what you actually need: a CRO who will build a sales process, manage a small team, and navigate medtech’s long buying cycles and compliance requirements. You are not hiring a generalist — you need someone who understands FDA regulatory timelines, hospital procurement, and the difference between selling to a surgeon versus a hospital administrator. The cost range reflects the CRO’s seniority, the number of days per month they commit, and whether you offer equity. Most fractional CROs in medtech will not relocate; they work remotely or travel to your site monthly.
Why Medtech Is Different from SaaS or General B2B
Medtech revenue leadership is not interchangeable with SaaS CRO skills. The buying process involves multiple stakeholders — surgeons, hospital administrators, value analysis committees, and sometimes GPOs — each with different priorities. Regulatory approval timelines (FDA 510(k), CE marking) directly affect sales cycles, and a CRO who doesn’t understand this will set unrealistic forecasts. Additionally, medtech often relies on distributor networks rather than direct sales, requiring a leader who can manage channel conflict and partner incentives. A fractional CRO with medtech experience will know how to price for reimbursement, navigate clinical trial data requirements, and structure sales compensation for long-cycle deals.
Medtech also has unique compliance risks. Off-label promotion, kickback laws, and Sunshine Act reporting are not afterthoughts — they shape how sales teams talk to providers. Your fractional CRO must have a track record of building compliant sales processes. If they come from a pure SaaS background, they will likely miss these landmines.
When to Choose Fractional vs. Full-Time
The decision hinges on predictability of revenue. If you have under $5 million in ARR and an unpredictable pipeline, a full-time VP of Sales is a high-risk bet. A fractional CRO lets you test leadership without a long-term commitment. If you have $10 million+ ARR with repeatable sales motions, a full-time hire may be justified, but many medtech companies still use fractional CROs to bridge gaps — for example, while searching for a permanent hire or during a product launch.
Equity is a negotiation lever. Founders often overvalue equity in a fractional arrangement. Be clear: the CRO’s equity should vest based on revenue milestones, not just time. This aligns incentives without giving away unnecessary ownership.
How to Evaluate a Fractional CRO’s Medtech Credentials
You cannot rely on a resume alone. Ask these questions:
- “Walk me through a deal you closed in medtech that involved a GPO.” Look for specifics about contract terms, pricing tiers, and how they handled pushback from hospital supply chain.
- “How did you handle a sales rep who made an off-label claim?” The answer should reference compliance training, documentation, and escalation procedures.
- “What is your experience with FDA 510(k) timelines?” A strong CRO will explain how regulatory delays affect pipeline velocity and how they adjust forecasting accordingly.
- “Have you managed distributor relationships in medtech?” If they only have direct sales experience, they may struggle with channel models.
Check references rigorously. Ask the reference: “What did this CRO do when a key deal slipped by six months due to regulatory issues?” The answer reveals whether they are a problem-solver or a finger-pointer.
What the Engagement Looks Like in Practice
A typical fractional CRO engagement for a medtech company follows this pattern:
- Month 1: Audit current sales process, CRM data quality (Salesforce or HubSpot), and team skills. Deliver a 60-day plan with specific pipeline targets.
- Month 2–3: Implement changes — revise sales scripts, train reps on medtech buying personas, set up Gong or Clari for deal tracking. Start coaching individual reps.
- Month 4–6: Focus on closing deals and refining the process. The CRO should be in the field or on calls with reps for key accounts.
- Month 7–12: Transition to a strategic role — the CRO should be working themselves out of a job, either by hiring a full-time VP of Sales or by making the team self-sufficient.
Important: The CRO should not be a permanent crutch. If they are still doing the same work after 12 months, either the engagement was mis-scoped or the CRO is not building capability.
The Role of Tools and Data
A fractional CRO should be proficient with the tools you already use — Salesforce or HubSpot for CRM, Gong or Clari for revenue intelligence, Outreach or Salesloft for sales engagement. They should not require you to buy new software just because they prefer a different stack. Data hygiene is non-negotiable. If your CRM is a mess, the CRO should clean it up within the first month, not ignore it. They should also be comfortable with medtech-specific data sources like Definitive Healthcare or IQVIA for market sizing and account targeting.
Warning: A CRO who insists on replacing your entire tech stack in the first 60 days is likely overengineering. Focus on process and people first, tools second.
Common Mistakes When Hiring a Fractional CRO
- Hiring a generalist. A SaaS CRO who has never sold to a hospital will waste months learning the market. Medtech is not “just another B2B vertical.”
- Under-scoping the engagement. If you only pay for 5 days per month, you get 5 days per month — don’t expect the CRO to attend every sales call or handle admin work.
- Ignoring equity vesting. Giving equity without performance milestones is a gift, not an incentive. Tie vesting to revenue growth or deal count.
- Skipping the trial period. A 3-month trial protects both sides. If it’s not working, part ways cleanly.
- Expecting the CRO to fix culture. A fractional leader can coach, but they cannot rebuild a broken sales culture in 10 days per month. That’s a founder’s job.
FAQ
What is the typical cash cost for a fractional CRO in medtech? Between $5,000 and $25,000 per month, depending on the CRO’s seniority, the number of days per month (10–20), and the complexity of your product (Class II vs. Class III devices). Equity is additional, typically 0.5%–2% vesting over 2–3 years.
How do I find a fractional CRO with medtech experience?
Can a fractional CRO work remotely for a medtech company? Yes, but expect travel for key customer meetings, team offsites, and regulatory audits. Most fractional CROs are based in major medtech hubs (Minneapolis, Boston, San Francisco, or remote) and will fly in as needed.
What happens if the fractional CRO doesn’t deliver? Your contract should include a 30-day termination clause. At the end of the 3-month trial, if milestones are unmet, you can part ways without severance. This is a major advantage over a full-time hire.
Should I offer equity to a fractional CRO? Yes, if you want alignment on long-term growth. But tie it to revenue milestones, not just time. For example, 1% equity vesting over 2 years, with 50% vesting upon reaching $5M ARR.
How do I know if I need a fractional CRO or a full-time VP of Sales? If your annual recurring revenue is under $5M and you have less than 10 sales reps, a fractional CRO is lower risk. Above $10M ARR with a repeatable process, a full-time hire may be better — but many medtech companies use fractional CROs as a bridge.
What tools should a fractional CRO be proficient in? At minimum, Salesforce or HubSpot for CRM, and one revenue intelligence tool (Gong, Clari, or similar). Medtech-specific tools like Definitive Healthcare are a bonus but not required.